166 302

Cited 9 times in

Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma

 Junhee Park  ;  Hyun-Jeong Kim  ;  Ki Rim Kim  ;  Sun Kyoung Lee  ;  Hyungkeun Kim  ;  Kwang-Kyun Park  ;  Won-Yoon Chung 
 ONCOTARGET , Vol.8(6) : 9079-9092, 2017 
Journal Title
Issue Date
Animals ; Carcinoma, Squamous Cell/genetics ; Carcinoma, Squamous Cell/metabolism* ; Carcinoma, Squamous Cell/mortality ; Carcinoma, Squamous Cell/pathology ; Cell Line, Tumor ; Cell Movement* ; Cell Proliferation ; Core Binding Factor Alpha 3 Subunit/genetics ; Core Binding Factor Alpha 3 Subunit/metabolism* ; Epithelial-Mesenchymal Transition ; G1 Phase Cell Cycle Checkpoints ; G2 Phase Cell Cycle Checkpoints ; Gene Expression Regulation, Neoplastic ; Head and Neck Neoplasms/genetics ; Head and Neck Neoplasms/metabolism* ; Head and Neck Neoplasms/mortality ; Head and Neck Neoplasms/pathology ; Humans ; Kaplan-Meier Estimate ; Male ; Mice, Inbred BALB C ; Mice, Nude ; Mouth Neoplasms/genetics ; Mouth Neoplasms/metabolism* ; Mouth Neoplasms/mortality ; Mouth Neoplasms/pathology ; Neoplasm Invasiveness ; Osteoblasts/metabolism ; Osteoblasts/pathology ; Osteolysis/genetics ; Osteolysis/metabolism* ; Osteolysis/pathology ; Paracrine Communication ; Parathyroid Hormone-Related Protein/metabolism ; RANK Ligand/metabolism ; RNA Interference ; Signal Transduction ; Skull/metabolism* ; Skull/pathology ; Time Factors ; Transfection ; Transforming Growth Factor beta/metabolism ; Tumor Microenvironment
bone invasion ; oral squamous cell carcinoma ; runt-related transcription factor 3 ; transforming growth factor-β
High recurrence and lower survival rates in patients with oral squamous cell carcinoma (OSCC) are associated with its bone invasion. We identified the oncogenic role of RUNX3 during bone invasion by OSCC. Tumor growth and the generation of osteolytic lesions were significantly inhibited in mice that were subcutaneously inoculated with RUNX3-knockdown human OSCC cells. RUNX3 knockdown enhanced TGF-β-induced growth arrest and inhibited OSCC cell migration and invasion in the absence or presence of transforming growth factor-β (TGF-β), a major growth factor abundant in the bone microenvironment. RUNX3 knockdown induced cell cycle arrest at the G1 and G2 phases and promoted G2 arrest by TGF-β in Ca9.22 OSCC cells. RUNX3 knockdown also inhibited both the basal and TGF-β-induced epithelial-to-mesenchymal transition by increasing E-cadherin expression and suppressing the nuclear translocation of β-catenin. In addition, the expression and TGF-β-mediated induction of parathyroid hormone-related protein (PTHrP), one of key osteolytic factors, was blocked in RUNX3-knockdown OSCC cells. Furthermore, treating human osteoblastic cells with conditioned medium derived from RUNX3-knockdown OSCC cells reduced the receptor activator of nuclear factor-kappaB ligand (RANKL)/osteoprotegerin ratio compared with treatment with conditioned medium from RUNX3-expressing cells. These findings indicate that RUNX3 expression in OSCC cells contributes to their bone invasion and the resulting osteolysis by inducing their malignant behaviors and production of osteolytic factors. RUNX3 alone or in combination with TGF-β and PTHrP may be a useful predictive biomarker and therapeutic target for bone invasion by oral cancer.
Files in This Item:
T201700358.pdf Download
Appears in Collections:
2. College of Dentistry (치과대학) > Dept. of Oral Biology (구강생물학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Nuclear Medicine (핵의학교실) > 1. Journal Papers
Yonsei Authors
Park, Kwang Kyun(박광균)
Park, Jun Hee(박준희)
Lee, Sun Kyoung(이선경) ORCID logo https://orcid.org/0000-0002-3707-8050
Chung, Won Yoon(정원윤) ORCID logo https://orcid.org/0000-0001-8428-9005
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.